Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Ardent Health, Inc. (NYSE:ARDT) have earned an average rating of “Hold” from the fifteen research firms that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $12.79.

A number of analysts recently commented on the stock. Wall Street Zen downgraded shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Truist Financial raised their target price on shares of Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. BMO Capital Markets began coverage on shares of Ardent Health in a research report on Tuesday, September 22nd. They issued a “market perform” rating and a $11.00 price target on the stock. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a report on Monday, September 7th. Finally, Guggenheim increased their price objective on Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Thursday, August 6th.

Institutional Investors Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently modified their holdings of ARDT. BlackRock Inc. purchased a new position in Ardent Health in the 2nd quarter worth about $21,415,000. Algert Global LLC lifted its stake in Ardent Health by 1,277.3% during the second quarter. Algert Global LLC now owns 597,745 shares of the company’s stock valued at $5,882,000 after buying an additional 554,345 shares in the last quarter. Empowered Funds LLC purchased a new stake in Ardent Health during the second quarter valued at about $5,425,000. Bank of America Corp DE acquired a new position in shares of Ardent Health in the second quarter worth about $3,840,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Ardent Health in the second quarter worth about $2,377,000.

Ardent Health Price Performance

Shares of Ardent Health stock opened at $10.36 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. The company’s 50-day moving average price is $10.86 and its two-hundred day moving average price is $9.99. Ardent Health has a 52 week low of $7.71 and a 52 week high of $15.48. The stock has a market cap of $1.46 billion, a PE ratio of 18.83, a price-to-earnings-growth ratio of 2.90 and a beta of 0.72.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, sell-side analysts anticipate that Ardent Health will post 0.96 EPS for the current fiscal year.

Ardent Health Company Profile

Ardent Health is a healthcare provider that operates hospitals, outpatient facilities and physician practices in the United States. The company delivers a broad range of services, including emergency and inpatient care, surgery, primary care, specialty care, diagnostic services and other outpatient treatments.

Ardent serves communities through regional health systems and affiliated medical groups, with operations primarily in Texas, Oklahoma, New Mexico and Kansas. Its facilities include acute-care hospitals as well as ambulatory and other sites designed to provide care closer to patients’ homes.

The company traces its roots to Ardent Health Services, a healthcare operator established in 1993.